Tegafur/gimeracil/oteracil-induced eosinophilic pneumonia.

Drug‐induced pneumonia TS‐1 eosinophilic pneumonia

Journal

Respirology case reports
ISSN: 2051-3380
Titre abrégé: Respirol Case Rep
Pays: United States
ID NLM: 101631052

Informations de publication

Date de publication:
May 2020
Historique:
received: 23 11 2019
accepted: 22 02 2020
entrez: 18 3 2020
pubmed: 18 3 2020
medline: 18 3 2020
Statut: epublish

Résumé

Clinicians should be aware that eosinophilic pneumonia is one of the types of drug-induced lung injury that can be caused by tegafur/gimeracil/oteracil (TS-1).

Identifiants

pubmed: 32180985
doi: 10.1002/rcr2.551
pii: RCR2551
pmc: PMC7063347
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e00551

Informations de copyright

© 2020 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology.

Références

Nihon Kokyuki Gakkai Zasshi. 2008 Mar;46(3):206-9
pubmed: 18409567
Nihon Kokyuki Gakkai Zasshi. 2011 Dec;49(12):949-54
pubmed: 22352058
Respirol Case Rep. 2020 Mar 10;8(4):e00551
pubmed: 32180985

Auteurs

Toshiyuki Sumi (T)

Department of Pulmonary Medicine Hakodate Goryoukaku Hospital Hakodate Japan.
Department of Respiratory Medicine and Allergology Sapporo Medical University School of Medicine Sapporo Japan.

Hisashi Nakata (H)

Department of Pulmonary Medicine Hakodate Goryoukaku Hospital Hakodate Japan.

Yuji Mori (Y)

Department of Pulmonary Medicine Hakodate Goryoukaku Hospital Hakodate Japan.

Hiroki Takahashi (H)

Department of Respiratory Medicine and Allergology Sapporo Medical University School of Medicine Sapporo Japan.

Classifications MeSH